Month: April 2026

When Nour gave birth earlier than expected, her baby girl had serious health complications. Suffering from a weak pulse, difficulty breathing, and lung inflammation, the infant was immediately placed in an incubator for 10 days. During this time, hospital restrictions prevented Nour from seeing her daughter until the fifth day. Not only did this cause emotional distress, but it also made breastfeeding impossible.

When the baby was discharged, Nour’s attempts to breastfeed were unsuccessful. The baby couldn’t latch properly, and Nour had never seen any signs of milk production. With no financial means to purchase formula, she faced a daunting situation.

Everything changed when Action Against Hunger team, with the financial support of the Spanish Agency for International Development Cooperation (AECID), visited Nour’s family during a community outreach. At that time, Nour herself was struggling with her health. Her Mid-Upper Arm Circumference (MUAC) measured 219 mm, indicating malnutrition. She was immediately referred for treatment.

The team provided one-on-one nutrition counseling to Nour and supported her to try breastfeeding again during the visit. They offered information on breastfeeding techniques, benefits, and safe practices. Following the team’s recommendations, Nour’s baby was finally able to latch well, and for the first, milk began to flow. Overwhelmed with joy and relief, Nour’s hope for her baby’s future was reignited.

Over the following weeks, Action Against Hunger’s regular follow-ups supported Nour’s journey. While her milk supply was still limited, she was determined to continue breastfeeding. However, when financial barriers prevented her from buying formula, and her milk supply became too low, she resorted to feeding the baby sugar water—an unsafe and desperate decision.

Upon discovering this, the health team quickly informed her of the dangers of sugar water for babies and encouraged her to use hand expression to stimulate milk production. She was provided with sterile cups and a manual breast pump to support the effort. After a few days, her perseverance paid off. Her milk supply increased, and her baby began to show real signs of improvement.

At that time, Nour’s family became displaced by the escalating conflict in southern Lebanon. Yet, amidst the upheaval, she confirmed that she was still exclusively breastfeeding, and her baby’s health was improving daily. Weeks later, another call with Action Against Hunger confirmed a heartening milestone—Nour’s baby was steadily gaining weight. Nour had been able to navigate health challenges, conflict, and financial constraints with incredible resilience.

Nour’s determination to care for her child was bolstered with the counseling and resources offered by Action Against Hunger. That kind of timely humanitarian support remains essential for other families in Lebanon who face similar challenges. Action Against Hunger has reached 35,137 people so far this year with multi-sectoral assistance across the country.

***

Action Against Hunger leads the global movement to end hunger. We innovate solutions, advocate for change, and reach 26.5 million people every year with proven hunger prevention and treatment programs. As a nonprofit that works across over 55 countries, our 8,500+ dedicated staff members partner with communities to address the root causes of hunger, including climate change, conflict, inequity, and emergencies. We strive to create a world free from hunger, for everyone, for good.

GENEVA, April 30, 2026 /3BL/ – The final installment of a three-part scientific State of Knowledge (SoK) paper series on tire wear emissions concludes that, while the understanding of tire wear emissions has advanced, current data to quantify human health impacts attributable to tire wear emissions remains inconclusive.

The review finds that differences in sampling approaches, detection techniques and analytical methodologies limit reliable comparison across studies and prevent robust risk assessment. In addition, based on the peer-reviewed literature studied, tire wear particles constitute only a small part of the overall airborne particulate matter, with similar or less potent effects compared to other particulate matter fractions.

Supported by the Tire Industry Project (TIP), part of the World Business Council for Sustainable Development (WBCSD), the SoK series represents the most comprehensive review of global science on tire wear emissions to date, analyzing more than 850 peer-reviewed scientific publications.

State of Knowledge series: Key findings from Paper 3

Independently authored by Kathrin Müller, Julie Panko, Kenny M. Unice, and Dr. Stephan Wagner, the paper Impacts of Tire Wear Emissions Compared to the Impacts of PM2.5 and PM10 on Humans reviews existing scientific knowledge on human exposure to tire and road wear particles (TRWP) and tire-related chemicals, concluding that:

• Tire wear particles make up only a small share of airborne particulate matter, typically less than 5% of PM 2.5 and PM 10 in urban environments.
• Toxicological studies to date do not show TRWP to be more harmful than general ambient particulate matter. Available in vivo and in vitro data indicates effects that are similar to or less potent than other airborne particle types.
• Despite growing interest, scientific evidence on human exposure to TRWP remains limited and inconclusive. Chemicals that are used in tire manufacturing are detectable in human body fluids, but their sources and exposure pathways have not been clearly linked specifically to tires, as many of these chemicals are used in a range of other applications.
• A major barrier to drawing firm conclusions is the lack of consistent global methods for sampling, analyzing, and characterizing tire wear emissions. Variability in methodologies across studies limits meaningful comparison and robust exposure or risk assessment.

Call for coordinated research efforts

As a result, the authors of the papers call for greater harmonization of research methodologies to improve identification, measurement and attribution of tire wear emissions. This need for coordinated efforts aligns with the conclusions of SoK Papers 1 and 2, which were published in 2025 and examined the characterization and quantification of tire wear emissions and their potential impacts on the environment.

The authors recommend that future research should identify potential exposure pathways and examine relevant health outcomes, including potential chronic effects, under realistic exposure conditions covering urban and suburban populations across different regions worldwide.

Dr. Stephan Wagner, one of the leading researchers of Paper 3, said: “Tire wear emissions are a complex topic that we still only partly understand, especially in relation to human health. While research has advanced our understanding of TRWP, the current data simply isn’t robust enough to quantify any potential health risks specifically linked to tire wear. Looking forward, cross-stakeholder collaboration is fundamental to making rapid progress. By aligning methods, sharing data, and focusing on real-world studies, we can build a stronger, more consistent evidence base to inform future decisions.”

Notes:

The State of Knowledge papers and supporting materials are available at https://tireparticles.info/our-research#sokpaper1, https://tireparticles.info/our-research#sokpaper2 and https://tireparticles.info/our-research#sokpaper3

• Kathrin Müller is a PhD Researcher at the Institute for Analytical Research (IfAR) at Hochschule Fresenius University of Applied Sciences in Idstein, Germany. Her PhD research is on the analysis of tire and road wear particles as environmental contaminants focusing on the identification of tire-borne environmental water contaminants.
• Julie Panko is Principal Scientist and Senior Vice President at ToxStrategies, a scientific consulting firm in the United States. She has more than 30 years of experience conducting and managing a wide variety of occupational, environmental, and consumer health risk assessments, including applied research regarding the potential for environmental impacts of tires throughout their lifecycle from manufacturing through end of life.
• Kenny Unice is Principal Computational Health Scientist at TRC Companies, Inc since 2026. Formerly a Principal Health Scientist and applied researcher at Stantec, he has more than 20 years’ experience investigating and driving understanding of how chemicals travel, persist or change in the environment to impact organisms and ecosystems.
• Dr. Stephan Wagner is Head of the Institute for Analytical Research at the Hochschule Fresenius University of Applied Sciences in Idstein, Germany. He is an expert in the analysis and fate of anthropogenic materials such as tire and road abrasion particles, micro and nano plastics, nano materials as well as organic trace contaminants in the (urban) water cycle.

GENEVA, April 30, 2026 /3BL/ – The final installment of a three-part scientific State of Knowledge (SoK) paper series on tire wear emissions concludes that, while the understanding of tire wear emissions has advanced, current data to quantify human health impacts attributable to tire wear emissions remains inconclusive.

The review finds that differences in sampling approaches, detection techniques and analytical methodologies limit reliable comparison across studies and prevent robust risk assessment. In addition, based on the peer-reviewed literature studied, tire wear particles constitute only a small part of the overall airborne particulate matter, with similar or less potent effects compared to other particulate matter fractions.

Supported by the Tire Industry Project (TIP), part of the World Business Council for Sustainable Development (WBCSD), the SoK series represents the most comprehensive review of global science on tire wear emissions to date, analyzing more than 850 peer-reviewed scientific publications.

State of Knowledge series: Key findings from Paper 3

Independently authored by Kathrin Müller, Julie Panko, Kenny M. Unice, and Dr. Stephan Wagner, the paper Impacts of Tire Wear Emissions Compared to the Impacts of PM2.5 and PM10 on Humans reviews existing scientific knowledge on human exposure to tire and road wear particles (TRWP) and tire-related chemicals, concluding that:

• Tire wear particles make up only a small share of airborne particulate matter, typically less than 5% of PM 2.5 and PM 10 in urban environments.
• Toxicological studies to date do not show TRWP to be more harmful than general ambient particulate matter. Available in vivo and in vitro data indicates effects that are similar to or less potent than other airborne particle types.
• Despite growing interest, scientific evidence on human exposure to TRWP remains limited and inconclusive. Chemicals that are used in tire manufacturing are detectable in human body fluids, but their sources and exposure pathways have not been clearly linked specifically to tires, as many of these chemicals are used in a range of other applications.
• A major barrier to drawing firm conclusions is the lack of consistent global methods for sampling, analyzing, and characterizing tire wear emissions. Variability in methodologies across studies limits meaningful comparison and robust exposure or risk assessment.

Call for coordinated research efforts

As a result, the authors of the papers call for greater harmonization of research methodologies to improve identification, measurement and attribution of tire wear emissions. This need for coordinated efforts aligns with the conclusions of SoK Papers 1 and 2, which were published in 2025 and examined the characterization and quantification of tire wear emissions and their potential impacts on the environment.

The authors recommend that future research should identify potential exposure pathways and examine relevant health outcomes, including potential chronic effects, under realistic exposure conditions covering urban and suburban populations across different regions worldwide.

Dr. Stephan Wagner, one of the leading researchers of Paper 3, said: “Tire wear emissions are a complex topic that we still only partly understand, especially in relation to human health. While research has advanced our understanding of TRWP, the current data simply isn’t robust enough to quantify any potential health risks specifically linked to tire wear. Looking forward, cross-stakeholder collaboration is fundamental to making rapid progress. By aligning methods, sharing data, and focusing on real-world studies, we can build a stronger, more consistent evidence base to inform future decisions.”

Notes:

The State of Knowledge papers and supporting materials are available at https://tireparticles.info/our-research#sokpaper1, https://tireparticles.info/our-research#sokpaper2 and https://tireparticles.info/our-research#sokpaper3

• Kathrin Müller is a PhD Researcher at the Institute for Analytical Research (IfAR) at Hochschule Fresenius University of Applied Sciences in Idstein, Germany. Her PhD research is on the analysis of tire and road wear particles as environmental contaminants focusing on the identification of tire-borne environmental water contaminants.
• Julie Panko is Principal Scientist and Senior Vice President at ToxStrategies, a scientific consulting firm in the United States. She has more than 30 years of experience conducting and managing a wide variety of occupational, environmental, and consumer health risk assessments, including applied research regarding the potential for environmental impacts of tires throughout their lifecycle from manufacturing through end of life.
• Kenny Unice is Principal Computational Health Scientist at TRC Companies, Inc since 2026. Formerly a Principal Health Scientist and applied researcher at Stantec, he has more than 20 years’ experience investigating and driving understanding of how chemicals travel, persist or change in the environment to impact organisms and ecosystems.
• Dr. Stephan Wagner is Head of the Institute for Analytical Research at the Hochschule Fresenius University of Applied Sciences in Idstein, Germany. He is an expert in the analysis and fate of anthropogenic materials such as tire and road abrasion particles, micro and nano plastics, nano materials as well as organic trace contaminants in the (urban) water cycle.

• Teva exceeded all sustainability-linked bond targets, linking financial performance to expanded patient access to medicines and reduced environmental impact.
• Through its global access to medicines programs, Teva reached nearly 8 million people through product donations around the world.
• 39% reduction in Teva’s Scope 1 and 2 GHG emissions since 2019 and 32% reduction in Scope 3 GHG emissions since 2020—exceeding 25% reduction targets.
• More than 99% of active employees completed compliance and ethics training. 
• Teva’s generic medicines contributed $36.4 billion in savings for healthcare systems across 21 countries.

TEL AVIV, Israel, April 30 /3BL/ – Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today published its 2025 Healthy Future Report, outlining performance against its sustainability targets, which are focused on the issues most relevant to its business, patients and the planet. Teva surpassed all 2025 targets associated with its sustainability-linked bonds—totaling approximately $7.5 billion across its 2021 and 2023 issuances. These commitments reflect progress in areas such as climate action, health equity and access to medicines, linking financial and sustainability performance.

“Advancing sustainability is fundamental to how we operate at Teva,” said Richard Francis, Teva’s President and CEO. “Our 2025 Healthy Future Report shows how we’re building the future we want to see—addressing global challenges by using our footprint, resources and skills to drive meaningful impact for our business and stakeholders.”

Healthy People 

Teva operates eight access to medicines programs focused on delivering life-changing treatments to underserved populations. Several programs incorporate health system strengthening and capacity-building components, reflecting a holistic approach to improving health outcomes. Through these efforts, Teva reached nearly 8 million people with product donations and approximately 399,000 people through health system strengthening initiatives worldwide.

Healthy Planet

Teva reduced greenhouse gas (GHG) emissions from its operations (Scopes 1 and 2) by 39% since 2019, surpassing its 25% target. The Company also reduced GHG emissions from its value chain (Scope 3)—which account for approximately 90% of its total GHG emissions—by 32% since 2020, exceeding its 25% target ahead of schedule. Teva continued transitioning to cleaner energy, with 60% of total electricity consumption sourced from renewables and 100% renewable electricity via three long-term power purchase agreements to date, which cover various Teva sites in Europe and Israel. In addition, 73% of applicable Teva sites reached safe discharge levels of antimicrobials—helping address antimicrobial resistance (AMR), a growing global health threat that reduces the effectiveness of medicines and makes infections harder to treat.

Healthy Business

Teva continues to uphold strong standards for responsible and ethical practices across its operations, including its supply chain. The Company evaluated 100% of all submitted Third-Party Representative business partners through its due diligence tool. In addition, 66% of significant suppliers (by spend) have undergone sustainability performance evaluations. Teva also maintained a strong culture of compliance, with more than 99% of active employees completing their assigned annual compliance and ethics training.

Teva’s generic medicines portfolio delivers substantial savings for healthcare systems, expanding patient access to essential medicines and strengthening the long-term sustainability of care. In 2025, Teva’s generic medicines contributed $36.4 billion in savings for healthcare systems across 21 countries.

Teva continues to be recognized and was ranked in the top 10% for its sector across most leading sustainability ratings, with scores improving across five of six priority benchmarks in 2025, including Sustainalytics, MSCI, S&P Global, EcoVadis and CDP (water). The Company was also named to TIME World’s Most Sustainable Companies for the second consecutive year.

By embedding sustainability priorities throughout its operations, Teva is strengthening its resilience while working towards a healthy future for people and the planet. 

Read the full 2025 Healthy Future Report to learn more.

About Teva

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is transforming into a leading innovative biopharmaceutical Company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how, visit www.tevapharm.com.

Cautionary Note Regarding Forward-Looking Statements

This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management’s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. Important factors that could cause or contribute to such differences include risks relating to: our ability to successfully compete in the marketplace; our significant indebtedness; our business and operations in general; compliance, regulatory and litigation matters; other financial and economic risks; and other factors discussed in this press release, and in our Annual Report on Form 10-K for the year ended December 31, 2025, including in the sections captioned “Risk Factors” and “Forward-Looking Statements.” Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.

Originally published in the CVS Health National Economic Impact Report

With more than 9,000 locations and 300,000 employees, CVS Health is a driving force in the American economy, delivering $474 billion in economic impact nationwide.

As one of the country’s largest private employers, we’re making health care more affordable and accessible for you and your family.

Discover how our economic footprint benefits communities across the U.S: creating jobs, fueling local investments and generating tax revenue that supports schools, emergency services, infrastructure and more.

With 192 locations, CVS Health is bringing high-quality and affordable care to Arizona communities, improving people’s health and driving economic growth.

$5.3 Billion in Economic Impact

CVS Health’s operations in Arizona generated an economic impact of $5.3B in FY24. This includes a direct impact of $2.6B, $972.5M indirect and $1.7B induced.

Source: Parker Strategy Group using data from CVS Health in IMPLAN

With multiple locations and prescription delivery services, CVS Health proudly serves patients and communities throughout Arizona.

Generating Labor Income

CVS Health generated $1.9B in total labor income in Arizona ($1B direct, $304.5M indirect and $553.9M induced) in FY24.

Source: Parker Strategy Group using data from CVS Health in IMPLAN

Supporting and Sustaining Jobs

Overall, CVS Health supported 26,467 jobs in Arizona in FY24 (13,829 direct employees, 4,465 indirect and 8,173 induced).

Source: Parker Strategy Group using data from CVS Health in IMPLAN

Contributing to the Local and State Tax Base 

CVS Health supported $381.1M in state and local taxes in Arizona as a result of operations and capital spending in FY24. State ($207.7M) and local taxes ($173.4M) paid include employment-related, business and consumption-based taxes.

Source: Parker Strategy Group using data from CVS Health in IMPLAN

Giving Back to the Community

• $33.2 Million in Community Support
• 4,491 Volunteer Hours

Source: CVS Health, 2024 Data

To learn more, Download national report and Explore impact by state

Methodology 

The study is a snapshot of economic impact as of December 31, 2024, unless otherwise noted. Data used to complete the economic analysis was provided by CVS Health. Data supplied included operating expenditures, capital spending, pay and benefits, direct taxes paid and total employees. The colleague data used in the analysis of the report represents the sum total of all colleagues who were in the state at any time in 2024. Average number of CVS Health colleagues reflects a point-in-time estimate in 2024. Primary and secondary data was used to complete the input-output models in IMPLAN. Additional jobs include indirect employment created as a result of CVS Health’s economic impact and induced employment as a result of household spending by CVS Health employees and employees of vendors. The CVS Health colleague and location data is as of January 1, 2025. Patient counts are not unique across mail, retail and specialty pharmacy. Numbers in this report are subject to rounding.

Originally published on Nielsen News Center

On October 9, 2025, a record number of Nielsen employees celebrated our 13th annual Nielsen Global Impact Day (NGID). As our company-wide day of service and a deeply valued tradition, NGID enables every employee to connect with each other while volunteering in their communities. This year saw the largest participation since 2022. More than 2,300 dedicated Nielsen employees across 37 countries volunteered over 10,300 hours to support more than 260 nonprofit organizations worldwide.

While NGID is led by Cares—one of our 15 Business Resource Groups (BRGs)—all employees and BRGs are encouraged to get involved in organizing and participating in volunteer events. Our employees cleaned up parks, packed and distributed food, visited schools and hospitals, volunteered virtually to advance citizen science and develop tips for youth on responsible use of AI, and much more.

One volunteering leader, Ria Encinas, Green Mexico Leader and Gracenote Content Operations Editor, said: “NGID 2025 confirmed that real impact stems from collective action. From our shelter donations to educational workshops, our efforts have made a difference and strengthened our community.”

This annual event is a cornerstone of our commitment to corporate citizenship and a powerful demonstration of our culture in action.

“Nielsen Global Impact Day is one of my favorite days of the year because it is a powerful expression of Our Nielsen Way in action,” said Nicolina Marzicola, Chief People Officer. “Watching our teams ‘Achieve Together’—applying their unique skills, passion, and enthusiasm to support our communities—is a source of immense pride. It reinforces our commitment to being accountable to the world around us and inclusive in our service.”

While Nielsen Global Impact Day is our largest single day of service, our commitment to community is year-round. Nielsen provides all employees with 24 hours of dedicated volunteer time annually, empowering them to support the causes they care about most, any day of the year.

We are proud of the impact made during NGID 2025 and look forward to continuing to make a difference, to power a better future for all by dreaming big and achieving together. Learn more about Nielsen’s commitments to responsibility and sustainability, including for our communities, in our 2025 Responsibility & Sustainability Report.

 

By Kristin Wyman

What you should know:

• The future of automotive cannot be delivered by any single company — it requires a deeply collaborative ecosystem that brings together automakers, tier-one suppliers, software innovators and connectivity leaders to transform technological breakthroughs into production-ready vehicles at global scale.
• Qualcomm Technologies provides scalable automotive solutions that are designed to serve as the hardware and software foundation for software-defined vehicles, while simultaneously orchestrating ecosystem partnerships that turn innovation into production-ready solutions for automakers worldwide.
• The Snapdragon Digital Chassis Solution is designed to offer openness and flexibility that can make advanced automotive AI real, scalable and sustainable — empowering OEMs with the option to choose their own automated driving (AD) stacks, integrate multiple partner solutions and continuously evolve their vehicles through over-the-air (OTA) updates.

The automotive industry is undergoing one of the most profound transformations in history. Vehicles are evolving into software-defined platforms — powered by AI, 5G connectivity and cloud computing — capable of improving safety, creating new experiences for drivers and passengers, and continuously evolving over their lifetimes. This shift is too complex for any single company to deliver alone. It requires an ecosystem.

At Qualcomm, we believe the future of automotive will be built through deep collaboration across silicon, software, systems and services — bringing together automakers, tier‑one suppliers, software innovators and connectivity leaders to turn breakthrough technology into production‑ready vehicles at global scale.

A platform foundation, and the ecosystem around it

The Snapdragon Digital Chassis Solution serves as the hardware and software foundation for the software-defined vehicle. However, a product solution alone is not enough to drive the industry forward. The ecosystem, working together, is equally crucial. From component manufacturers to software developers, global OEMs to regional specialists, established tier-ones to emerging startups are all needed for this transformation. World-class silicon is just the beginning. The magic happens when tier-one suppliers and software partners transform our platform into production-ready systems that automakers can deploy at scale.

Tier-one suppliers bridge the gap between semiconductor innovation and production vehicles, transforming our platform technologies into complete, validated systems that meet rigorous automotive safety and performance standards. For example, our expanded collaboration with Valeo delivers a pre-integrated ADAS and automated driving platform that combines Snapdragon Ride computing power with Valeo’s sensor expertise, parking algorithms and system integration capabilities that can enable automakers to bring next-generation driving experiences to market faster and more efficiently.

Meanwhile, we’re integrating our Snapdragon Cockpit Elite platform with HARMAN’s Ready product portfolio to enable AI-powered features like the Luna AI avatar for emotionally responsive interaction, AR-rich visualization for safety-critical information and intelligent driver monitoring — transforming vehicles into connected, personalized environments.

Software partners like Google provide the engineering horsepower to deliver the operating systems, middleware, AI algorithms and applications that define user experiences and differentiate vehicles. Qualcomm Technologies’ collaboration with Google began in 2016 with the first embedded Android experience powered by Snapdragon. Today, this has evolved to integrate Google Cloud’s Automotive AI Agent with our Snapdragon Digital Chassis, bringing agentic AI capabilities to vehicles that enable multimodal, edge-to-cloud intelligence for more personalized and intuitive driving experiences.

Earlier this year at CES 2026, we celebrated this decade-long collaboration with Google by announcing that Qualcomm Technologies is now a lead scaling partner for Android Automotive OS. The multi-year agreement is designed to provide automakers with pre-optimized software, virtual Snapdragon SoCs on Google Cloud, and a unified reference platform that simplifies the deployment of advanced AI agents and accelerates the transition to software-defined vehicles.

Connectivity partners enable the connectivity essential for OTA updates, remote diagnostics, real-time navigation and agentic, cloud-based services that define next-generation mobility, not just for four-wheeled vehicles but for two-wheelers and micromobility solutions as well. Through collaborations with companies like HARMAN and Royal Enfield’s Flying Flea, we’re bringing purpose-built connectivity platforms designed specifically for the unique constraints of two-wheelers including limited space, harsh environmental conditions and strict power requirements.

Open architecture for automated driving

Automated driving represents one of the industry’s most complex challenges. Rather than dictating a single approach, we’ve built an open, collaborative ecosystem supporting multiple AI strategies.

Our 20+ Snapdragon Ride Platform design wins are driven by our open, scalable AD architecture, aimed at allowing partners to integrate advanced stacks into production-ready systems. OEMs can choose the AD stack that best fits their needs — all running on the same platform. You can see this in action in the all-new BMW iX3, which debuted the AI-enabled Snapdragon Ride Pilot Automated Driving System, which is designed to support everything from entry-level safety features to Level 2+ highway and urban automated driving.

Turning ecosystem innovation into vehicles on the road

Our OEM collaborations translate ecosystem innovation into production vehicles across every segment and market:

• Qualcomm Technologies and Volkswagen Group
• Qualcomm Technologies  and Hyundai Mobis
• Qualcomm Technologies and Leapmotor
• Qualcomm Technologies and Mercedes-Benz

While collaborations with global OEMs demonstrate scale, collaborations with emerging market champions, such as India and China, showcase our commitment to democratizing advanced automotive technology. These partners are moving faster and taking big bets on new technologies, helping us validate and scale innovations that will eventually reach global markets.

Enabling the next era of agentic AI

The transition to agentic AI requires even deeper ecosystem collaboration. Integrating generative AI models, advanced sensor fusion and cloud-native architecture demands collaborations that span traditional industry boundaries. With Google Cloud, for example, we brought together Google’s Gemini-powered Automotive AI Agent with Snapdragon Digital Chassis Solutions to enable multi-modal, hybrid edge-to-cloud AI that can anticipate driver needs, adapt in real-time and provide proactive assistance.

Success through collaboration

Qualcomm Technologies’ commitment to ecosystem collaboration is rooted in the belief that the greatest innovations emerge from diverse perspectives working toward shared goals. As the industry continues toward software-defined, AI-powered and connected mobility, we’ll continue growing our ecosystem and deepening collaborations that drive industry-wide progress.

The future of automotive isn’t just about building better technology — it’s about building a better future together.

Read the latest ADAS news from Qualcomm Technologies
Learn more about the future of automotive experiences from Qualcomm Technologies

Today, Chemours announced the recipients of its sixth annual Responsible Supplier Awards, recognizing suppliers that have delivered meaningful improvements in sustainability performance, operational excellence, and responsible business practices.

As Chemours continues to advance its vision of delivering Trusted Chemistry, suppliers who demonstrate leadership, integrity, and innovation across the value chain play a critical part. Each year, the company celebrates those partners that help fulfill that vision through the Responsible Supplier Awards, which spotlight organizations that embody Chemours’ expectations for responsible procurement and sustainability.

The 2025 award recipients were selected from a global network of suppliers and exemplify the continuous progress that Chemours looks for in advancing a more resilient and sustainable supply chain. The winners include GEA Group AG (Star Supplier Award), Freji Transportación Especializada SA de CV (Logistics Category), MPW Industrial Services Inc (Indirect Category), Rio Tinto (Direct Category), and Palmer Tool LLC (Capital Category).

“At Chemours, delivering Trusted Chemistry depends on working with those who share our commitment to continuous improvement. The Responsible Supplier Awards recognize partners who move beyond compliance—strengthening sustainability performance while helping reduce risk and build resilience across our supply chain,” emphasized Gladys Gabriel, Chemours’ Vice President and Chief Procurement Officer. “Their leadership reflects our approach to responsible procurement: collaborate to raise standards, challenge what’s possible, and deliver lasting value for customers and communities.”

This year’s honorees distinguish themselves not only through strong performance, but through their active partnership with Chemours to improve processes, elevate sustainability standards, and spark innovation across shared value chains. Their work advances Chemours’ commitment to responsible sourcing—promoting ethical conduct, environmental stewardship, and continuous improvement at every stage of the supplier relationship.

All Chemours suppliers that maintain a valid sustainability scorecard are eligible for consideration. Additional details on Chemours’ responsible procurement approach and awards are available at: www.chemours.com/en/supplier-center/responsible-procurement.